broad neutralis germlinelik human monoclon antibodi dengu virus envelop domain zhongyu shun yongqiang yanl nana vinita chunyu peng cheng xiaolong yulu wei ponraj jane chengfeng xiaohui dimitr tianlei moe nhc cam key labouratori virolog basic scienc shanghai fudan shanghai nation institut nation institut frederick maryland unit state shanghai key labouratori virolog ministri educ fudan shanghai state key labouratori pathogen biosecur beij institut epidemiolog beij institut communiti univers malaysia sarawak malaysia author contribut equal current address sanofi genzym ave framingham massachusett unit state current address antibodi therapeut pittsburgh pittsburgh pennsylvania unit state zhouxiaohui shphc pitt edu dsd tli fudan edu dengu widespread vectorborn viral diseas caus dengu virus denv safe effect drug approv use use sequen tial antigen pan yeast antibodi librari deriv healthi donor denv envelop protein domain diii combin deplet entri defect diii mutant identifi crossreact human monoclon antibodi mab bound high affin denv diii denv serotyp immunogenet indic germlinelik mab somat mutat clos germlin gene import demonstr potent neutralis denv vitro mous model denv infect without detect antibodi depend enhanc ade epitop map high conserv region diii guid design effect dengu vaccin immuno gen furthermor germlinelik mab deriv antibodi librari neutralis denv serotyp tool explor mecha nism denv infect promis therapeut candid dengu virus infect million peopl infect initi entri virus cell mediat viral envelop glycoprotein close relat open citat zhu deng broad neutralis germlinelik human monoclon antibodi dengu virus envelop domain plos pathog https ppat ana fernandezsesma icahn mount sinai unit state publish copyright openaccess free copyright freeli reproduc distribut transmit modifi built otherwis use anyon law purpos made creativ common domain dedic data avail statement relev data within support inform file fund support nation natur foundat niaid intramur biodef programmem intramur programmem nih nci ccr feder fund nih nci contract well pittsburgh funder role plos pathogen https ppat design data collect decis publish prepar compet interest author declar compet interest exist broad neutralis germlinelik human monoclon antibodi dengu virus denv serotyp antigen distinct compris sever genotyp exhibit differ infect characterist mosquito vector human host confound problem face vaccin biolog drug decad inabl antibodi serotyp protect infect instead induc humour immun dengu virus infect enhanc infect diseas process brought infect dengu serotyp use competit sort strategi interrog human antibodi librari identifi crossreact mab design denv serotyp mab possess somat mutat closest germlin gene high affin diii import germlinelik demonstr broad spectrum neutralis denv serotyp promis candid therapeut epitop impli design effect vac immunogen elicit antibodi vivo introduct dengu virus denv caus preval mosquitoborn viral diseas billion peopl risk infect countri million infect symp tom dengu hemorrhag fever dhf dengu shock syn drome dss specif antivir drug denv infect approv vaccin dengvaxeia caus consider controversi ing safeti potenti benefit decad antidenv vaccin biolog drug hamper high sequenc diverg denv serotyp diverg lead fact antibodi suf ficient neutralis denv infect instead induc humour immun denv infect enhanc infect diseas process brought infect denv serotyp find broad neutralis antibodi serotyp denv promi ing candid antidenv agent guid design effect safe vaccin immunogen denv envelop glycoprotein protein mediat virus entri cell major neutralis target antibodi protein type fusion protein consist domain dii diii diii propos receptor bind domain reveal crossreact conserv epitop exist dii well diii denv protein naturallyoccur pri mari denv infect larg fraction antibodi repertoir consist diispecif anti bodi unfortun typic poor neutralis likelihood sever diseas infect mechan anti bodydepend enhanc ade contrast antibodi target diii proven potent neutralis antibodi elicit natur infect individu despit indic antidenv diii serotypespecif crossreact antibodi elicit use denv diii vac immunogen infect human demonstr lysin posit diii critic residu crossreact epitop conserv epitop diii repres attract target broad neutralis denv antibodi plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus report isol potent denv diiispecif human monoclon antibodi mab design larg antibodi librari construct blood healthi adult donor competit sort strategi use diii mutant competitor identifi antibodi precis target conserv neutralis epitop human mab isol antibodi librari neutralis serotyp denv virus import heavi light chain gene close putat germlin predecessor fulli human origin germlinelik combin highaffin broad neutralis activ denv serotyp promis candid antivir agent provid uniqu templat design effect dengu vaccin immunogen result isol generat broad neutralis mab previous prepar larg antibodi librari use peripher blood lympho cyte nonimmunis healthi donor use pan screen viral target use competit librari sort strategi iso late broad neutralis antibodi yeastdisplay singl chain antibodi fragment scfv librari use screen biotinyl denv diii import ten time concentr unbiotinyl diii mutant use competitor yeast cell select antibodyexpress cell bind well wildtyp diii instead diii mutant result isol antibodi target crossreact neutralis epitop cover residu potent enrich achiev round sort panel antibodi identifi antibodi design bound yeast displaybas biopan isol denv diiispecif antibodi denv protein consist dii diii cyan light pink respect scfv display rose fusion protein surfac yeast antibodi express detect use fluoresc anticmyc antibodi bind scfv biotinyl diii detect use peconjug streptavidin hemagglutinin variabl light chain variabl heavi chain flexibl peptid linker schemat scfv pan process biotinyl diii fluoresc tag colour use antigen biopan ten time concentr unbiotinyl diii mutant use competitor mac facsbas sort strategi use isol high affin binder yeastdisplay antibodi librari https ppat plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus bind kinet diiispecif mab measur biacor koff koff koff koff diii diii diii diii https ppat potent denv diii scfv fuse human protein expr sion surfac plasmon reson spr experi use evalu antigen bind equilibrium dissoci constant diii respect mab display broader bind profil compar respect fig affin denv serotyp struct mutant librari use errorpron pcr technolog cycl mutagenesi select clone identifi enrich pool yeast sort design biacor show crossreact bind activ diii preserv affin matur pro cess diii respect bind diii improv slight increas bind affin diii compar parent mab notabl exhibit high affin denv diii respect demonstr bind serotyp denv virus high avid assess bind specif elisa result show weak crossreact zika virus zikv diii bind irrelev antigen neutralis activ vitro next assess neutralis capac denv serotyp use denv luciferas report viral particl rvp neutralis assay use denv rvps dengu serotyp common strain denv westpac luminesc report express proport number rvps bhk dcsign cell confirm linear correl extent rvp infect report express consist biacor bind result neutralis serotyp denv display neutraliza tion neutralis titer respect plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus bind denv diii serotyp measur biacor immobilis onto chip analyt consist serial dilut diii bind kinet fit use langumir bind model biaevalu softwar https ppat evalu neutralis breadth igg denv sero type standard plaqu reduct neutralis assay prnt cell form use live virus includ genbank isol infect patient guangzhou genbank genbank genbank irrelev human mab use control broad neutralis mab denv serotyp use pos itiv control igg neutralis denv sero type neutralis titer respect ade assay vitro next use wellestablish ade assay detect vitro ade igg mutat form igg generat contain leucin alanin substitut posit igglala lack bind receptor ade effect igg igglala well measur interest neither igg igglala present ade differ serotyp denv contrast potent ade effect diispecif mab result show igg denv diiispecif mab without detect ade immunogenet analys sequenc mab use imgt tool identifi closest germlin gene result indic origin differ ent bcell lineag deriv plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus neutralis ade effect antibodi differ serotyp denv mix serial dilut mab neutralis activ evalu plaqu reduct assay triplic use cell result exhibit percentag plaqu reduct independ neutralis experi perform duplic incub serial dilut mab cell virus supernat infect cell quantifi plaqu assay data dot indic limit detect result repres independ experi https ppat contrast deriv interest encod gene close resembl correspond germlin segment notabl share sequenc ident germlin respect result cate mab germlinelik antibodi general show drug properti lower immunogen compar somat hypermut antibodi valu mab mab igg https ppat genet heavi light chain variabl region denv diiispecif antibodi mab variabl region https ppat variabl region ident vrtpynwndgprgaldi arymagiwtfdi gawdsrlsavv qvwarssdlpnwv plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus immunogenet immunogenet heavi lightchain variabl region use imgt tool germlineroot circular phylogenet tree antibodi sequenc igm librari deriv healthi human adult naeonat sequenc show highest similar sequenc start repres sequenc deriv naeonat start repres sequenc deriv healthi adult phylogenet tree construct neighbourjoin method https ppat immunogenet characterist antibodi ana lyze detail recombin frequenc specif ighd ighj gene famili immunoglobulin igm repertoir adult donor neo natal igm repertoir newborn babi use nextgener sequenc data previous generat antibodyom queri sequenc igm repertoir sequenc display recombin gene total sequenc healthi adult igm repertoir igm repertoir newborn babi recombin fre quenci sequenc recombin sequenc show frequent use ighv gene identifi mani sequenc share signific degre resembl brief data show potenti elicit robust immun respons germlin antibodi vaccin vivo protect infect mice determin protect denv infect vivo first use lethal infect suckl mous model mice challeng pfu mous via intracrani inject hour later mice treat intracrani singl dose igg igglala mutant unrel antibodi control anim monitor morbid mortal daili mice control group die denv infect die within week viral challeng interest signific differ therapeu tic efficaci infect lalamut igg protect infect plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus vivo therapeut efficaci infect group suckl mice administr mab hour challeng pfu respect unrel antibodi use control number anim group rang kaplanmei surviv curv analys logrank test compar curv control https ppat lalamut protect respec tive detect ade confirm vitro vivo experi use typesi ifn receptor defici mice test therapeut result show mice control antibodi group die surviv rate mice reach group indic antibodi protect lethal infect mice result indic protect infect vivo epitop map map epitop germlinelik mab identifi greater detail struc tural basi denv neutralis employ multipl approach sequenc align differ denv genotyp map conserv amino acid residu denv diii show serotyp denv diii amino acid residu differ amino acid subsequ serotyp deriv diii consensus random mutat construct yeastdisplay mutant librari round sort yeast cell show express surfac lack bind perform total bind escap mutant align serotyp consensus protein sequenc mutat frequenc posit plot residu posit number similar uniqu diii sequenc deriv natu ralli isol serotyp dengu virus genebank align consensus sequenc superimpos profil set sequenc show mani escap mutat locat wellconserv area indic broad cross reactiv natur isol dengu virus besid epitop map show epitop close partial overlap dimer interfac plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus epitop map denv diii sequenc align differ flavivirus residu epitop map domain sort diii mutant librari escap mutat colour domin map lower region denv diii pdb code colour cyan colour magenta indic map epitop sequenc variat diii escap mutant natur isol denv diii deriv genbank ribbon represent denv diii scfv dock model experiment identifi epitop contact residu model surfac heavi light chain colour cyan respect cdrs label distinct structur proxim epitop region differ colour smudg lime label residu number putat locat model https ppat domain result explain potent crossreact antibodi denv serotyp furthermor comput dock denv antibodi complex form use zdock method select top score dock complex tain key residu identifi epitop map top score dock model exhibit minimum clash appropri protein interfac parametr use lactat potenti epitop interac tion antibodi shed light mechan broad crossreact neutralis show dock model antibodi complex epitop highlight surfac dock model reveal differ orient antibodi bind compar diii complex structur fab previous determin epitop compris structur proxim region residu dark ctermin lime key residu contact germlin mutat complex structur residu tact hydrophob residu trp contact part epitop loop involv bind surfac area interfac diii antibodi model complex typic antibodyantigen interact hydrogen bond like form salt bridg plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus interfac brief bind region close partial overlap dimer interfac domain indic broad cross reactiv serotyp denv dengu diseas complex immun orchestr host cell partial presenc serotyp denv import primari denv infect protect aggrav secondari infect differ serotyp bring mani difficulti develop effect vaccin urgent develop effect crossreact antivir therapi denv infect monoclon antibodi mab grow import protect pathogen immun respons virus mani therapeut antibodi viral infect antibodi sarscov merscov nipah hendra virus influenza virus fortun screen antibod larg librari enabl highaffin human mab especi outbreak emerg virus diseas recent success identifi human germlinelik mab merscov influenza virus librari name respect natur exist low level somat hypermut librari potent bind activ envelop protein merscov influenza virus import show high therapeut effect anim model librari screen quick use isol germ linelik antibodi effect bind complex protein target denv virus neutralis breadth key develop antidenv antibod reveal class broad neutralis antibodi flavivirus includ antibodi target conserv epitop dii diii conserv fusion loop epitop fle dii immunodomin epitop protein unfortun epitop frequent induc poor neutralis strong infect enhanc antibodi via ade diii repres ideal target neutral ize antibodi high effici yeastdisplaybas sort strategi use high divers denv diii antigen competit sort appli method quick effici identifi human germlinelik broad spectrum antidenv mab scfv yeast librari use diii antigen make promis candid therapeut well templat vaccin class high effici broad neutralis antibodi target envelop dimer epitop ede secondari acut denv infect plasmablast identifi dejnirattisai antibodi especi get high somat mutat secondari virus infect compar high somati calli mutat antibodi germlinelik antibodi typic safeti drugrel properti import hendra nipah antibodi germlin anti bodi exhibit good drugabl librari use isol antibodi success candid thera peutic mab anim model complet phase trial without side effect affin serotyp denv diii subject affin matur process name subsequ analys sequenc use imgt tool identifi closest germlin gene interest germlinelik antibodi went mutat process vitro plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus ident gene germlin respect order evalu neutralis igg use standard plaqu reduct neutralis cell measur denv infect neutralis igg show broad neutralis toward serotyp denv well denv isol sampl import ade effect differ serotyp denv vivo result demonstr thera peutic potenti sever infect brief neu traliz serotyp denv vitro protect denv infect mous model vivo without detect ade effect expect like drugabl develop candid therapeut futur localis epitop use combin comput struc tural model displaybas antigen mutagenesi sequencebas mutant epitop overlap epitop previous explor target crossreac murin mab close partial overlap dimer interfac domain indic epitop import compon vaccin immunogen intend elicit crossreact neutralis antibodi experi crystallis complex denv diii precis determin epitop major result identif germlinelik human mab yeast antibodi librari bind high picomolar affin diii serotyp neutralis denv serotyp major implic find potenti candid therapeut develop preclin set epitop germlinelik mab guid design effect candid vaccin immunogen capabl elicit antibodi materi method line virus cell cultiv dulbecco modifi eagl medium dmem supplement foetal bovin serum fbs biowest mosquito cell cultur rpmi medium supplement fbs cell maintain humidifi atmo sphere incub except cell cultiv genbank isol infect patient guangzhou genbank genbank genbank propag cell use rpmi medium titer measur standard plaqu form assay cell protein express purif denv diii gene serotyp synthesis genescript inc nanj fuse ctermin avitag clone psectag express vector diii serotyp mutant generat overlap pcr convers scfv heavi light chain scfv amplifi reclon vector plasmid transfect cell thermo fisher tran sient express purifi use protein column healthcar piscataway manufactur instruct purifi protein biotinyl mix plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus biotinyl reagent pbs ice manufactur instruc tion pierc antibodi screen yeast librari larg yeastdisplay scfv librari use antibodi screen screen proto col essenti carri previous briefli binotinyl diii cell initi librari mix wash pbsa incu bate streptavidin conjug microbead miltenyi biotec auburn load onto automac system miltenyi biotec sort round sort ing downsiz librari sort binotinyl diii use unbiotinyl mutant competitor cell stain addit mous anticmyc antibodi roch conjug goatantimous antibodi invitrogen peconjug streptavidin invitrogen sort facsaria sorter biocsienc san jose isol binder plasmid clone prepar use zyppi plasmid miniprep kit manu factur instruct zymo mutant librari construct errorpron dna shuffl pcr generat scfv scfv mutant librari random mutagenesi scfv gene perform errorpron pcr use genemorph kit stratagen fol low manufactur instruct minor modif diversifi mutat profil nucleotid analogueu tri phosphat triphosph mix pcr reaction mix ture cycl librari construct extra step dna shuffl pcr insert regular pcr cycl benefici mutat obtain matur process dna shuffl pcr step perform cycl denatur second follow anneal extens biorad mycycl affin determin surfac plasmon reson bind affin scfv scfv scfv scfv denv diii analys surfac plasmon reson technolog use biacor instru ment healthcar antibodi coval immobilis onto sensor chip use carbodiimid coupl control refer surfac prepar nonsp cific bind refract index chang kinet interact vari concentr antigen inject flow rate use run buffer tain hepe nacl edta surfact associ dissoci phase data fit simultan langumir global model use nonlinear data programmem biaevalu experi done denv prnt neutralis activ mab measur use standard plaqu reduct neutralis cell previous briefli serial dilut mab approxim pfu varieti dengu virus strain incub mixtur monolay plate duplic incub mixtur lmp agaros plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus promega dmem plus fbs layer onto infect cell incu bation day well stain crystal violet dissolv formaldehyd visualis plaqu valu determin use nonlinear regress data calcul nonlinear regress use sigmaplot systat softwar inc previous denv rvp neutralis assay denv rvps serotyp preincub equal serial dilut antibodi predilut pre dilut measur base dilut antibodi prior combin rvps dmem infect media room temperatur transfer well plate equal denv rvps well follow slow agit room temperatur bhk dcsign cell well densiti cell well follow incub cell subsequ fix lyse analys luminesc report express use wallac victor cent infect concentr mab serum calcul raw data express percent infect mab concentr reciproc serum dilut data fit sigmoid doserespons curv use prism graphpad soft ware determin titer antibodi achiev reduct infec tion maxeimum infect determin absenc antibodi denv ade assay vitro ade assay perform use cell briefli serial dilut antibodi concentr rang mix incub mixtur cell mul tiplic infect plate cell subsequ wash time serum free medium collect cell centrifug pel let resuspend medium contain fbs plate incub day titer virus supernat measur use plaqu assay ade calcul differ viral yield supernat infect presenc antibodi epitop map diii mutant librari sort epitop map perform use previous protocol briefli random mutagenesi denv diii perform use genemorph kit stratagen yeastdisplay mutant librari mix bioti nylat scfvfc wash stain mous anticmyc antibodi roch alexa conjug goatantimous antibodi invitrogen peconjug streptavidin invi trogen round sort facsaria sorter biocsienc san jose sort cell amplifi plasmid prepar sequenc comput dock antibodi complex homolog model variabl region heavi light chain scfv antibodi carri use swissmodel workspac select closest templat structur pdb code heavi chain light chain whose sequenc similar respect vhvl orient scfv structur assign templat pdb code show plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus minimum steric clash creat final scfv model crystal structur denv diii serotyp pdb code use dock model scfv antibodi dock scfv dengu enviii perform zdock server zdock edu use fast fourier transform fft base rigidbodi protein dock ing algorithm score function combin pairwis shape complementar desolv electrostat energi base escap mutant led loss epitop crystal structur denv diii select residu biolog constrain surfac envdiii potenti contact resi due dock constraint similar residu loop chosen dock interfac loop domin hydrophob residu germlin mutat high antigencontact propens result top zdock predict philtre use user defin residu angstrom distanc cutoff predict complex kept residu select interfac examin pdbepisa protein interfac surfac assembl pymol use dock model graphic illustr vivo therapeut experi suckl mice purchas univers group limit shanghai hous specif pathogenfre condit anim facil shanghai fudan shanghai infect mice transfer anim biosafeti level labouratori shanghai mice use experi mice intracerebr inject pfu post infect mice passiv transfer singl dose anti bodi igg igg lala mutant igg control via intracer bralli inject surviv rate diseas sing monitor daili mice type type interferon receptordefici purchas univers group limit shanghai hous specif pathogenfre condit anim facil shanghai fudan shanghai infect mice transfer labouratori shanghai group mixedsex mice use experi mice intraperitonne inject pfu post infect mice passiv transfer singl dose antibodi igglala antibodi control via inject surviv rate weight loss diseas sing monitor daili ethic statement specificpathogenfre mice week suckl mice use exper iment protocol review approv institut committe fudan permit number accord guidelin ethic anim welfar nation council nhmrc support inform bind denv diii serotyp measur biacor immobilis onto chip analyt consist serial dilut diii plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus bind kinet fit use langumir bind model biaevalu softwar tif bind denv diii serotyp measur biacor immobilis onto chip analyt consist serial dilut diii bind kinet fit use langumir bind model biaevalu softwar tif bind denv diii serotyp measur biacor immobilis onto chip analyt consist serial dilut diii bind kinet fit ted use langumir bind model biaevalu softwar tif bind denv diii zikv diii protein measur elisa tif broad neutralis denv serotyp infect denv rvps serotyp rvps westpac serial dilut dmem bhk dcsign cell cell cultur cell lyse examin report express independ neutralis experi form duplic tif sequenc dengu virus isol infect patient guangzhou tif ade activ antibodi incub serial dilut mab cell virus supernat infect cell quantifi plaqu assay data dot indic limit detect tif vivo therapeut efficaci infect therapeut efficaci mice treat intraperitonne igglala viral challeng pfu monitor daili day accumul mortal group unrel antibodi use control group tif acknowledg thank professor dane wittrup provid yeast display vector yeast strain contribut conceptu dimitr dimitrov tianlei ying plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus zhongyu zhu shun yongqiang deng yanl nana vinita puri chunyu peng cheng xiaolong tian yulu zhao wei ponraj prabakaran feng jane cardosa chengfeng qin supervis xiaohui zhou dimitr dimitrov tianlei ying write origin draught zhongyu zhu write edit tianlei ying refer deen harri will balmaseda hammond dengu classif case definit reassess lancet https pmid kyle harri global spread persist dengu annu rev microbiol https annurev micro pmid aguiar stollenwerk halstead risk behind dengvaxeia recommend lancet infecti diseas https pmid aguiar stollenwerk dengvaxeia age surrog serostatus lancet infecti dis eas https pmid fatima dengvaxeia controversi vaccin hesit glob https jogh pmid martinezvega carrasquila luna ramoscastaneda ade dengu vaccin vaccin https vaccin pmid halstead dengu lancet https pmid dejnirattisai jumnainsong onsirisakul fittonn vasanawathana crossreact antibodi enhanc dengu virus infect human https pmid marasco growth potenti human antivir monoclon antibodi therapeu tic biotechnolog https pmid modi ogata clement harrison variabl surfac epitop crystal structur dengu virus type envelop glycoprotein virol https jvi pmid roehrig bolin kelli monoclon antibodi map envelop glycoprotein dengu virus jamaica virolog https viro pmid bedouell belkadi england guijarro lisova divers junction residu hotspot bind energi antibodi neutralis dengu virus feb https pmid thullier demangel bedouell megret jouan map dengu virus neu traliz epitop critic infect serotyp insight neutralis mechan gen virol https pmid huerta chinea fleita sarria sanchez character interact domain envelop protein dengu virus putat receptor cho cell virus res https virusr pmid crill roehrig monoclon antibodi bind domain dengu virus glycoprotein effici blocker virus adsorpt vero cell virol https jvi pmid pierson fremont kuhn diamond structur insight mechan anti bodymedi neutralis flavivirus infect implic vaccin host microb https chom pmid fibriansah lok therapeut antibodi dengu virus antivir res https antivir pmid lai tsai lin kao antibodi envelop glycoprotein dengu virus natur cours infect predomin crossreact recognis epitop contain high conserv residu fusion loop domain virol https jvi pmid plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus dejnirattisai supasa wongwiwat rouvinski barbaspaeth dengu virus serocrossreact drive antibodydepend enhanc infect zika virus nat immunol https pmid priyamvada quick hudson onlamoon sewatanon human antibodi respons dengu virus infect high crossreact zika virus proc natl acad sci https pnas pmid alwi beltramello messer sukupolvipetti wahala indepth antibodi individu expos primari dengu virus infect plos trop dis https pntd pmid balsiti william lachica flore kyle lethal antibodi enhanc dengu diseas mice prevent modif plos pathog https ppat pmid beltramello william simmon macagno simonelli human immun dengu virus domin high crossreact antibodi endow neutralis enhanc activ host microb https chom pmid sukupolvipetti austin engl brien dowd structur function therapeut monoclon antibodi dengu virus type virol https jvi pmid shrestha brien sukupolvipetti austin edel ther apeut antibodi neutralis homolog heterolog genotyp dengu virus type plos pathog https ppat pmid rajamanonmani nkenfou clanci yau shochat mous monoclon antibodi neutralis dengu virus serotyp gen virol https vir pmid sukupolvipetti austin purtha oliph nybakken type subcom plexspecif neutralis antibodi domain dengu virus type envelop protein recog nize adjac epitop virol https jvi pmid gromowski roehrig diamond pitcher mutat antibodi bind energi hot spot domain dengu envelop glycoprotein exploit neutralis escap virolog https virol pmid matsui gromowski barrett character dengu typespecif epitop dengu virus envelop protein domain gen virol https vir pmid liu liu xiao transmissionblock antibodi mosquito ctype lectin dengu prevent plos pathog https ppat pmid matsui gromowski schuh character dengu complex reactiv epitop dengu virus envelop protein domain virolog https virol pmid gromowski barrett barrett character dengu virus complexspecif neu traliz epitop envelop protein domain dengu virus virol https jvi pmid gromowski barrett character antigen site domin type specif neutralis determin envelop protein domain dengu virus virolog https virol pmid hiramatsu tadano lai mutat neutralis epitop dengu type virus envelop protein monoclon antibodi resist chimaera exhibit reduc mous neurovirul virolog https viro pmid lok kostyuchenko nybakken holdaway battisti bind neutraliz ing antibodi dengu virus alter arrang surfac glycoprotein nat struct mol biol https nsmb pmid guzman hermida bernardo ramirez guillen domain envelop protein dengu vaccin target expert rev vaccin https erv pmid bernardo pavon hermida gil vald compon adjuv potenti protect immun induc dengu recombin fusion protein mice vaccin https vaccin pmid plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus bernardo fleita pavon hermida guillen antibodi induc dengu virus type envelop domain recombin protein monkey neutralis strain differ geno type clin vaccin immunol https cvi pmid liu liu cheng vaccin immunis strategi dengu prevent emerg microb infect https emi pmid izquierdo bernardo martin santana hermida serotypespecif recombi nant fusion protein contain domain dengu virus virus res https virusr pmid simmon nelson hay evalu protect efficaci recombi nant dengu envelop domain fusion protein dengu virus infect mice trop hyg https ajtmh pmid simmon murphi hay report antibodi respons mice immunis tetraval dengu recombin protein subunit vaccin trop hyg https ajtmh pmid srivastava putnak warren hoke mice immunis dengu type virus fusion protein made escherichia coli protect lethal dengu virus infect vaccin pmid midgley bajwajoseph vasanawathana limpitikul will indepth anali sis origin antigen dengu virus infect virol https jvi pmid alwi beltramello messer sukupolvipetti wahala indepth antibodi individu expos primari dengu virus infect plos trop dis https pntd pmid rothman dengu defin protect patholog immun clin invest https pmid wahala kraus haymor accavittilop silva dengu virus neutraliza tion human immun role envelop protein domain iiireact antibodi virolog https virol pmid song chang potent germlinelik human monoclon anti bodi target phsensit epitop influenza hemagglutinin host microb https chom pmid ying prabakaran lau except potent neutralis middl east respiratori syndrom coronavirus human monoclon antibodi virol https jvi pmid ying prabakaran shi feng junction allelespecif residu criti cal merscov neutralis except potent germlinelik antibodi nat commun https pmid seaman zhu saha erad tumour simulta neous ablat tumour cell tumour vasculatur https ccell pmid fri shah orenta stetlerstevenson yuan car cell induc remiss ball naiv resist car immunotherapi nat https pmid hong wen indepth human naeonat adult igm antibodi repertoir front immunol https fimmu pmid jin dimitrov ying human monoclon antibodi candid therapeut emerg virus front https pmid puri streaker prabakaran zhu dimitrov high effici select epitop spe cific antibodi competit yeast display librari sort mab https mab pmid sun human monoclon antibodi small envelop pro tein hepat virus potent neutralis mab https pmid shi deng tan bispecif antibodi effect neutralis serotyp dengu virus simultan block virus attach fusion mab https pmid plos pathogen https ppat broad neutralis germlinelik human monoclon antibodi dengu virus deng jiang broad flavivirus crossneutralis mono clonal antibodi recognis epitop within fusion loop protein plos https pone pmid dimitrov therapeut antibodi vaccin antibodyom mab https mab pmid huang kang pancera tonneg broad potent neutralis human antibodi bind interfac https pmid huang ofek laub louder doriaros broad potent neutralis human antibodi https pmid zhou georgiev structur basi broad potent neutraliza tion antibodi https pmid gao cao feng human infect avianorigin influenza virus engl https pmid geisbert mire geisbert chan agan therapeut nipah virus infect nonhuman primat neutralis human monoclon antibodi sci transl zhu chakraborti robert sheahan potent crossreact neutralis sar coronavirus isol human monoclon antibodi proc natl acad sci https pnas pmid zhu nonneutralis antibodi induc nhr domain gain neutralis activ presenc hiv fusion inhibitor enfuvirtid poten tial therapeut vaccin strategi virol https jvi pmid dejnirattisai wongwiwat supasa class high potent broad neutralis antibodi isol virem patient infect dengu virus nat immunol https pmid biasini bienert waterhous arnold studer swissmodel model pro tein tertiari quaternari structur use evolutionari inform nucleic acid res https nar pmid maccallum martin thorntonn antibodyantigen interact contact bind site topographi mol biol https jmbi pmid mooer simplifi enhanc use pymol horizont script protein sci https pro pmid plos pathogen https ppat